Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 7.80% vs -1.91% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -68.57% vs 20.69% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -44.09% vs -21.85% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is -5.26% vs 46.15% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 7.80% vs -1.91% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -15.05% vs 84.94% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -68.57% vs 20.69% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -92.72% vs 487.18% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -44.09% vs -21.85% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -79.28% vs 560.53% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -5.26% vs 46.15% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 63.64% vs -21.43% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






